SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001400482-16-000242
Filing Date
2016-10-19
Accepted
2016-10-18 20:26:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 8-K acucela8-k_20161019xagmres.htm 425 55233
2 EXHIBIT 99.1 exhibit991-pressreleasexag.htm EX-99.1 22423
3 EXHIBIT 99.2 exhibit992-acucelaxnoticer.htm EX-99.2 15862
4 finalpressrelease202t_image1.gif GRAPHIC 2778
  Complete submission text file 0001400482-16-000242.txt   99157
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filed by) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-55133 | Film No.: 161941734
SIC: 2834 Pharmaceutical Preparations